These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10948033)

  • 1. Drug treatment of multiple sclerosis.
    Polman CH; Uitdehaag BM
    BMJ; 2000 Aug 19-26; 321(7259):490-4. PubMed ID: 10948033
    [No Abstract]   [Full Text] [Related]  

  • 2. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta.
    McDonald WI; Miller DH; Thompson AJ
    Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255
    [No Abstract]   [Full Text] [Related]  

  • 3. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis.
    Gout O
    Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028
    [No Abstract]   [Full Text] [Related]  

  • 4. Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?
    Giacomini PS; Arnold DL; Bar-Or A; Antel JP
    Arch Neurol; 2009 Jan; 66(1):19-20. PubMed ID: 19139295
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.
    Paty DW; Li DK; Oger JJ; Kastrukoff L; Koopmans R; Tanton E; Zhao GJ
    Ann Neurol; 1994; 36 Suppl():S95-6. PubMed ID: 8017896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis therapy. A practical guide.
    van Oosten BW; Truyen L; Barkhof F; Polman CH
    Drugs; 1995 Feb; 49(2):200-12. PubMed ID: 7729328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon beta in multiple sclerosis: how much BENEFIT?
    Pittock SJ
    Lancet; 2007 Aug; 370(9585):363-4. PubMed ID: 17678997
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with beta-interferon should be started already after the first attack of MS].
    Söderström M
    Lakartidningen; 2001 Feb; 98(6):587-90, 593-4. PubMed ID: 11475246
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta interferons for multiple sclerosis.
    Med Lett Drugs Ther; 2002 Oct; 44(1141):88-9. PubMed ID: 12381969
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon beta-1a during a first demyelinating event.
    Poser CM
    N Engl J Med; 2001 Jan; 344(3):229; author reply 229-30. PubMed ID: 11188840
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon beta-1a during a first demyelinating event.
    Esmonde TF
    N Engl J Med; 2001 Jan; 344(3):229; author reply 229-30. PubMed ID: 11188841
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of interferon-beta in the treatment of multiple sclerosis.
    Derwenskus J; Lublin FD
    Adv Neurol; 2006; 98():257-71. PubMed ID: 16400838
    [No Abstract]   [Full Text] [Related]  

  • 13. [A short history of beta-interferon therapy of multiple sclerosis].
    Stock G; Horowski R
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple sclerosis. Not only gait, but thinking is also affected].
    MMW Fortschr Med; 2002 May; Suppl 2():86. PubMed ID: 12070865
    [No Abstract]   [Full Text] [Related]  

  • 16. More immunotherapy for multiple sclerosis.
    Hughes RA; Sharrack B
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):239-41. PubMed ID: 8795592
    [No Abstract]   [Full Text] [Related]  

  • 17. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE
    West J Med; 1994 Sep; 161(3):292-8. PubMed ID: 7975569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Time is brain' also in multiple sclerosis.
    Freedman MS
    Mult Scler; 2009 Oct; 15(10):1133-4. PubMed ID: 19808740
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].
    Losy J
    Neurol Neurochir Pol; 2000; 34(3 Suppl):63-9. PubMed ID: 10983302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.